NRXP
Nrx Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$1.91
+0.23 (+13.69%)
Open$1.72
Previous Close$1.68
Day High$1.92
Day Low$1.71
52W High$23.47
52W Low$9.24
Volume—
Avg Volume403.2K
Market Cap56.55M
P/E Ratio21.61
EPS$0.77
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+1,014.1% upside
Current
$1.91
$1.91
Target
$21.28
$21.28
$14.65
$21.28 avg
$27.46
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 21.55M | 19.28M | 24.16M |
| Net Income | 2.70M | 1.92M | 2.84M |
| Profit Margin | 12.5% | 10.0% | 11.8% |
| EBITDA | 4.73M | 4.55M | 5.86M |
| Free Cash Flow | 2.93M | 1.59M | 2.98M |
| Rev Growth | +2.0% | +3.7% | +21.2% |
| Debt/Equity | 0.67 | 0.51 | 0.56 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |